Clinical Trials Browser

Phase 2 × Interleukin-2 × Gastrointestinal × Clear all

NCT06884670 2025-09-08

Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT03610490 2025-04-17

Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma

Phase 2 Terminated

16 enrolled 11 charts

GastrointestinalGynecologic

Ovarian Neoplasms, Colorectal Neoplasms

NCT04011033 2024-10-08

Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC

Phase 2 Completed

60 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT05810792 2023-11-22

PANCEP-1

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01795976 2018-08-07

ATTACK-OG

Phase 2 Terminated

Gastrointestinal

Esophageal Neoplasms

NCT03222089 2018-03-27

Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT00176761 2006-09-11

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

Phase 2 Terminated

Gastrointestinal

Colorectal Neoplasms